Whalesbook
Hester Biosciences has disclosed that Ravin and Bela Gandhi have requested their substantial shareholdings, totaling approximately 9.45% of voting rights, be reclassified from 'Promoter' to 'Public' status. The company is beginning the formal process under SEBI regulations. This request follows Ravin Gandhi's resignation from the Board of Directors just days prior.
This reclassification, if approved, could significantly alter the company's promoter group structure. It would mean Ravin and Bela Gandhi are no longer classified as promoters, indicating they would cease to be deemed as influencing or controlling the company's management or policy decisions, according to SEBI criteria.
Ravin Gandhi, who held a significant stake and board position, resigned from Hester Biosciences' Board of Directors on May 12, 2026. This resignation came before the formal submission of his and Bela Gandhi's requests for share reclassification on May 14, 2026.
Approval of the reclassification could lead to a reduced direct stake and perceived control by the promoter group. Regulatory bodies will review the applications, and shareholders will be advised to monitor future disclosures on the status of these requests. The market will also watch for any subsequent impacts on company management or strategic direction.
Key risks include potential delays in obtaining approvals from SEBI or the stock exchanges, and uncertainty surrounding the final outcome of the reclassification process.
Direct listed peers in the Indian veterinary pharmaceutical and vaccine sector are scarce. Hester Biosciences operates in a specialized niche. Global players like Zoetis are significant but not directly comparable in the Indian listed market. Other diversified life sciences companies like Zydus Lifesciences may have animal health divisions, but it is not their primary focus.
As of May 14, 2026, Ravin Gandhi held 4.74% of voting rights, and Bela Gandhi held 4.71%. Their combined shareholding before the reclassification request was approximately 9.45%.
Investors should track the company's progress in processing these applications under SEBI (LODR) Regulations, any official communication from SEBI or stock exchanges, and subsequent announcements detailing the final classification status. The market will observe how any approved change might affect the promoter group's overall control and future disclosures.